Welcome to our dedicated page for NextPlat news (Ticker: NXPL), a resource for investors and traders seeking the latest updates and insights on NextPlat stock.
NextPlat Corp (NXPL) operates at the intersection of global e-commerce solutions and specialized healthcare services through its Progressive Care subsidiary. This news hub provides investors and stakeholders with centralized access to official announcements, strategic developments, and operational updates.
Find timely information on earnings reports, technology partnerships, regulatory milestones, and acquisition activity across both business segments. Our curated feed simplifies tracking NXPL's progress in digital marketplace innovation and healthcare logistics solutions.
Discover updates about the company's global expansion initiatives, IoT-enabled services, and pharmaceutical data management advancements. Bookmark this page for direct access to verified information about NextPlat's integrated business model and market positioning.
NextPlat (NASDAQ: NXPL) reported Q2 2025 financial results, with revenue of $13.2 million, down from $17.0 million in Q2 2024. The company experienced a 66% reduction in net loss to $1.8 million ($0.07 per share) compared to $5.3 million in Q2 2024. Operating expenses decreased significantly to $4.7 million from $16.8 million year-over-year.
The company's Healthcare Operations faced challenges with decreased pharmacy prescription revenue and 340B contract revenue, while e-Commerce Operations showed growth in connectivity products and services. Gross profit margin declined to 21.8% from 34.5% year-over-year. The company ended Q2 with $16.6 million in cash and expects annual expense savings of over $1.0 million from operational improvements.
NextPlat (NASDAQ: NXPL), a global consumer products and services company, has scheduled its Q2 2025 earnings release for August 14, 2025, before market open. The company will host a conference call at 8:30 a.m. EDT on the same day.
The earnings call will be led by Interim CEO and President of Global Operations David Phipps and CFO Cecile Munnik. Investors can submit questions for the Q&A session by August 12, 2025, via email to investors@nextplat.com. The call will be accessible through toll-free and international dial-in numbers, with a replay available until August 21, 2025.
NextPlat (NASDAQ: NXPL) has issued an interim CEO update following the unexpected passing of former CEO Charles M. Fernandez. Interim CEO David Phipps outlined the company's strategic direction, focusing on two main divisions: Healthcare and E-Commerce.
In the Healthcare division, which represents the largest part of their business, NextPlat plans to expand contracted 340B and long-term care services, implement operational efficiencies, and pursue specialty medication accreditation. Key initiatives include exploring nationwide licensing for e-Commerce mail-order sales, adding compounding services, and targeting non-insured cash sales.
For the E-Commerce division, despite facing challenges from U.S.-China tariffs affecting product launches like their Florida Sunshine vitamin brand, the company aims to scale globally through strategic acquisitions, new marketplace launches, and partnerships. Notable developments include expanding their partnership with OPKO Health (NASDAQ: OPK) for health product sales in China and exploring UK/EU markets for their vitamin brand.
The company has also committed to implementing a previously announced stock buyback program and improving shareholder transparency while focusing on generating positive operating results.
NextPlat Corp (NASDAQ: NXPL), a global e-Commerce provider, has scheduled its first quarter 2025 financial results release for May 15, 2025, before market open. The company will host a conference call the same day at 8:30 a.m. EDT to discuss Q1 2025 results and recent developments.
The call will be led by Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and President and CEO of Global Operations David Phipps. Investors can submit questions for the Q&A session before May 12, 2025, via investors@nextplat.com. The conference call will be available for replay until March 22, 2025, through both the company's investor relations website and a dedicated replay line.
NextPlat (NASDAQ: NXPL) has received notification from Nasdaq regarding non-compliance with the minimum bid price requirement, as its shares traded below $1.00 for 30 consecutive business days. The company has been granted a 180-day period until October 27, 2025 to regain compliance by maintaining a closing bid price above $1.00 for at least 10 consecutive business days.
CEO Charles M. Fernandez addressed challenges including drug pricing issues and US-China tariff impacts on their e-Commerce operations. The company is focusing on:
- Reducing operating expenses
- Improving business efficiency
- Maximizing cash position value
If compliance isn't achieved by the deadline, NextPlat may qualify for an additional 180-day period. The company's shares will continue trading on Nasdaq during this period while management explores options to address the deficiency.
NextPlat Corp (NASDAQ: NXPL) announced that its subsidiary, Global Telesat Communications (GTC), has secured a one-year extension for a wireless connectivity services contract from an African military customer. The contract, initially awarded in Q1 2024, includes Iridium Push-To-Talk (PTT) device hardware and airtime services, with options for additional future purchases.
The extension represents a continuation of what was previously the largest contract of its type in the company's history. The hardware and airtime services sales under this contract are not affected by recent US tariffs. The Iridium Extreme® PTT devices provide instant, secure, and reliable global communication, particularly valuable for government, military, and enterprise customers operating in challenging environments.
NextPlat Corp (NASDAQ: NXPL) announced it will pause certain initiatives within its e-Commerce development program due to increased US/China tariffs on US-produced goods. The company is specifically halting plans for its Florida Sunshine brand of vitamins and supplements in the Chinese market, as the tariffs would significantly impact import costs and competitive positioning against local products.
Despite these challenges, NextPlat will continue selling OPKO Health Europe (OPKO) products in China, including nutraceuticals, supplements, and pet care items, as these are not US-produced and therefore not subject to the additional tariffs. The company is exploring opportunities to sell Florida Sunshine products in other markets.
NextPlat Corp (NASDAQ: NXPL) announced that its subsidiary, Global Telesat Communications (GTC), has secured a new contract from a central UK Government department to provide Iridium Push-To-Talk (PTT) devices and recurring airtime services.
This marks GTC's first contract with this senior governmental department, with initial product shipments expected during the second quarter. The devices will support staff connectivity for policy development, coordination, and implementation duties.
The Iridium Extreme® PTT devices offer instant, secure, and reliable global communication capabilities, featuring rugged durability and advanced push-to-talk functionality for challenging environments. The products are unaffected by recent US tariffs.